SCHEMBL6311758

SCHEMBL6311758

CCCCN1CCNC(=O)c2sc3ccc(OCC)cc3c21

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 12/20 0.44
CDK1 P06493 11/20 0.44
PRKD1 Q15139 2/20 0.42
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
ALOX12 P18054 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LRRK2 Q5S007 1/20 0.36
CCR4 P51679 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PARP1 P09874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6320313 0.94 MAPKAPK2 (0.46) MAPKAPK2CDK1PRKD1KDM4EALDH1A1
SCHEMBL6315169 0.91 MAPKAPK2 (0.56) MAPKAPK2CDK1PRKD1KDM4EALDH1A1
SCHEMBL6313553 0.86 MAPKAPK2 (0.44) MAPKAPK2CDK1PRKD1MAPTTDP1
SCHEMBL6319930 0.84 CDK1 (0.37) MAPKAPK2CDK1PRKD1ALDH1A1MAPT
SCHEMBL6312417 0.84 CDK1 (0.37) MAPKAPK2CDK1PRKD1MAPTMEN1
SCHEMBL6314267 0.84 MAPKAPK2 (0.58) MAPKAPK2CDK1PRKD1KDM4EALDH1A1
SCHEMBL6319967 0.84 MAPKAPK2 (0.43) MAPKAPK2CDK1PRKD1KDM4EALDH1A1
SCHEMBL6311862 0.81 MAPT (0.40) MAPKAPK2CDK1PRKD1MAPTTDP1
SCHEMBL6313881 0.80 MAPKAPK2 (0.60) MAPKAPK2CDK1PRKD1KDM4EALDH1A1
SCHEMBL6312661 0.78 MAPKAPK2 (0.55) MAPKAPK2CDK1PRKD1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250765-A1 Diazepinones as antiviral agents CHO HIDETSURA 2005-11-10 US claimed
US-20040116410-A1 Diazepinones as antiviral agents CHO HIDETSURA (JP) 2004-06-17 US claimed
WO-2002014324-A2 DIAZEPINONES AS ANTIVIRAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-02-21 WO claimed
US-20050250765-A1 Diazepinones as antiviral agents CHO HIDETSURA 2005-11-10 US disclosed
US-20040116410-A1 Diazepinones as antiviral agents CHO HIDETSURA (JP) 2004-06-17 US disclosed
WO-2002014324-A2 DIAZEPINONES AS ANTIVIRAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250765-A1 Diazepinones as antiviral agents ZC3HAV1, ECI1, ZC3HAV1L MAPKAPK2 3952/4885CDK1 274/4885PRKD1 3179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.